DMRA
Damora Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
—
13F top-10 QoQ
Top fund weight
Damora Therapeutics, Inc.
Expected move
InputsNext report
Last report
—
Largest filed tie
—
13F top-10 QoQ
Top fund weight
22.46
+0.38 · +1.71%
No filed income statement.
No reported quarters.
No open-interest data.
Bar = avg |move| to ±5% · tick = ±4.9% avg day · ×base = |move| ÷ ±4.9% · min 6 releases
| Quarter | Reported | EPS | Consensus |
|---|---|---|---|
| Q2 FY26 | — | -0.39 | — |
| Q1 FY26 | — | -0.62 | — |
| Q3 FY25 | — | -2.36 | — |
Source: filed financials
No implied move.
Expected move
No implied move.